{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-22-010938","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.630014+00:00","generated_at":"2026-06-22T22:30:22.312990+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tonix receives Nasdaq deficiency notice for minimum bid price; 180-day cure period","bullets":["Received Nasdaq notice on Oct 25, 2022 for non-compliance with minimum bid price $1 per share.","Has until April 24, 2023 to regain compliance; bid price must close at $1+ for 10 consecutive days.","If unmet, may seek additional 180-day period by meeting other listing standards and filing cure intent.","Stock not immediately delisted; company monitoring price and evaluating options to cure."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-22-010938","json":"https://secwatch.observer/filing/0001387131-22-010938.json","markdown":"https://secwatch.observer/filing/0001387131-22-010938.md","text":"https://secwatch.observer/filing/0001387131-22-010938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122010938/0001387131-22-010938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122010938/tnxp-8k_102522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:30:22.312990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2caa9feb0992e62304fcd9b9034441e2969574d3","claim":"Tonix Pharmaceuticals Holding Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"October 25, 2022, the Company received a letter (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq listing rules, the Company has been provided a period of 180 calendar days, or until April 24, 2023, in which to regain complianc","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122010938/0001387131-22-010938-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}